Zusammenfassung
Die Synthese von Arginin-Vasopressin, Lysin-Vasopressin und Oxytocin, deren Glycinrest eine14C-Markierung trägt, wird mit Hilfe der Festkörpermethode nachMerrifield beschrieben.
Literatur
R. B. Merrifield, J. Am. chem. Soc.85, 2149 (1963).
R. B. Merrifield, inRecent Progress in Hormone Research (Ed.G. Pincus; Academic Press, New York 1967), vol. 23, p. 451.
H. Hayatsu, Protein Nucleic Acid Enzyme13, 869 (1968).
F. Cramer andH. Köster, Angew. Chem.80, 488 (1968).
H. Hayatsu andH. G. Khorana, J. Am. chem. Soc.89, 3880 (1967).
L. R. Melby andD. R. Strobach, J. Am. chem. Soc.89, 450 (1967).
J. Meienhofer, A. Trzeciak, T. Douša, O. Hechter, R. T. Havran, I. L. Schwartz andR. Walter, inPeptides 1969 (Ed.E. Scoffone; North-Holland Pub. Co., Amsterdam, in press).
J. Meienhofer, A. Trzeciak, R. T. Havran andR. Walter, J. Am. chem. Soc.,92, 7199 (1970).
E. Schnabel, Annln Chem.702, 188 (1967).
J. Ramachandran andC. H. Li, J. org. Chem.27, 4006 (1962).
G. W. Anderson andA. C. McGregor, J. Am. chem. Soc.79, 6180 (1957).
J. Honzl andJ. Rudinger, Colln Czech. chem. Commun.20, 1190 (1955).
V. du Vigneaud, M. F. Bartlett andA. Jöhl, J. Am. chem. Soc.79, 5572 (1957).
J. A. MacLaren, W. E. Savige andJ. M. Swan, Aust. J. Chem.11, 345 (1958).
H. C. Beyerman, C. A. M. Boers-Boonekamp andH. M. v. d. Brink-Zimmermannová, Recl Trav. chim. Pays-Bas Belg.87, 257 (1968).
G. W. Anderson, J. E. Zimmerman andF. M. Callahan, J. Am. chem. Soc.86, 1839 (1964).
C. Meyers, R. T. Havran, I. L. Schwartz andR. Walter, Chemy Ind.1969, 136.
V. du Vigneaud, D. T. Gish, P. G. Katsoyannis andG. P. Hess, J. Am. chem. Soc.80, 3355 (1958).
D. B. Hope, V. V. S. Murti andV. du Vigneaud, J. biol. Chem.237, 1563 (1962).
The Pharmacopeia of the United States; 17th Revision (Mack Publishing Co., Easton, Pa. 1965), p. 749.
R. Walter, J. Rudinger andI. L. Schwartz, Am. J. Med.42, 653 (1967).
M. Bodanszky andV. du Vigneaud, J. Am. chem. Soc.81, 5688 (1959).
J. Meienhofer andY. Sano, J. Am. chem. Soc.90, 2996 (1968).
D. Yamashiro, Nature201, 76 (1964).
R. A. Munsick, W. H. Sawyer andH. B. van Dyke, Endocrinology66, 860 (1960).
St. Guttman, Helv. chim. Acta49, 83 (1966).
J. W. M. Baxter, M. Manning andW. H. Sawyer, Biochemistry8, 3592 (1969).
Author information
Authors and Affiliations
Additional information
Supported by National Institutes of Health grants No. AM-13567 and No. AM-10080 and the Atomic Energy Commission.
Abbreviations follow the rules of the IUPAC-IUB Commission on Biochemical Nomenclature in Biochemistry5, 2485 (1966). All optically-active amino acids are ofl-configuration. The following additional abbreviations were used: N-hydroxysuccinimide ester (OSu), ethanol (EtOH), methanol (MeOH), acetic acid (AcOH),n-butanol (n-BuOH), pyridine (Pyr) and N,N′-dicyclohexylcarbodiimide (DCCI). Protected peptides and hormones were visualized on thinlayer plates according to the procedure byH. Zahn andE. Rexroth, Z. analyt. Chem.148, 181 (1955). The biological activities of the hormones were measured against the U.S.P. Posterior Pituitary Reference Standard; the four-point design was used for these bioassays and standard errors were calculated according to the method ofC. I. Bliss,The Statistics of Bioassay (Academic Press, New York, N.Y. 1952).
Acknowledgments. The authors wish to thank Mr.D. Schlesinger for some of the amino acid derivatives used, and MissM. Wahrenburg and Mrs.A. Silverman for bioassays.
Rights and permissions
About this article
Cite this article
Walter, R., Havran, R.T. Arginine-vasopressin, lysine-vasopressin, and oxytocin, C14-labeled in the glycine residue. Experientia 27, 645–646 (1971). https://doi.org/10.1007/BF02136937
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF02136937